Arctic Bioscience Financials
| ABS Stock | NOK 1.94 0.05 2.51% |
Arctic |
Understanding current and past Arctic Bioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Arctic Bioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in Arctic Bioscience's assets may result in an increase in income on the income statement.
Arctic Bioscience Stock Summary
Arctic Bioscience competes with Airthings ASA, Aega ASA, Huddly AS, Bergenbio ASA, and Circa Group. Arctic Bioscience AS, a biotechnology company, provides nutraceutical and pharmaceutical products. Arctic Bioscience AS was incorporated in 2011 and is based in rsta, Norway. ARCTIC BIOSCIENCE is traded on Oslo Stock Exchange in Norway.| Foreign Associate | USA |
| Instrument | Norway Stock View All |
| Exchange | Oslo Stock Exchange |
| Business Address | Industrivegen 42, rsta, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.arctic-bioscience.com |
| Phone | 47 95 29 33 84 |
| Currency | NOK - Kroner |
You should never invest in Arctic Bioscience without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Arctic Stock, because this is throwing your money away. Analyzing the key information contained in Arctic Bioscience's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Arctic Bioscience Key Financial Ratios
There are many critical financial ratios that Arctic Bioscience's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Arctic Bioscience reports annually and quarterly.Arctic Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Arctic Bioscience's current stock value. Our valuation model uses many indicators to compare Arctic Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arctic Bioscience competition to find correlations between indicators driving Arctic Bioscience's intrinsic value. More Info.Arctic Bioscience AS is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arctic Bioscience's earnings, one of the primary drivers of an investment's value.Arctic Bioscience Systematic Risk
Arctic Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Arctic Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on Arctic Bioscience correlated with the market. If Beta is less than 0 Arctic Bioscience generally moves in the opposite direction as compared to the market. If Arctic Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Arctic Bioscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Arctic Bioscience is generally in the same direction as the market. If Beta > 1 Arctic Bioscience moves generally in the same direction as, but more than the movement of the benchmark.
Arctic Bioscience December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Arctic Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Arctic Bioscience AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Arctic Bioscience AS based on widely used predictive technical indicators. In general, we focus on analyzing Arctic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Arctic Bioscience's daily price indicators and compare them against related drivers.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 97.69 | |||
| Value At Risk | (15.97) | |||
| Potential Upside | 13.22 |
Other Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.